参 考 文 献 [1] Leighty L, Li N, Diaz LN, et al. Experimental models for the autoimmune and inflammatory blistering disease, bullous pemphigoid. Arch Dermatol Res, 2007, 299(9): 417-422. [2] Giudice GJ, Emery DJ, Zelickson BD, et al. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol, 1993, 151(10): 5742-5750. [3] Zillikens D, Rose PA, Balding SD, et al. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol, 1997, 109(4): 573-579. [4] 王刚,刘玉峰. 大疱性类天疱疮患者噬菌体抗体库的构建及抗BP180-NC16A抗体筛选.中国皮肤性病学杂志,2008, 22(11): 655-657. [5] 孙娜娜,王欲晓,周丽君,等. 人源性抗大疱性类天疱疮抗原BP180-NC16A单链抗体的构建及表达.中国皮肤性病学杂志, 2009, 23(2): 71-74. ?6? Liu Z, Diaz LA, Troy JL, et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest, 1993, 92(5): 2480-2488. ?7? Nishie W, Sawamura D, Goto M, et al. Humanization of autoantigen. Nat Med, 2007, 13(3): 378-383. ?8? Liu Z, Giudice GJ, Swartz SJ, et al. The role of complement in experimental bullous pemphigoid. J Clin Invest, 1995, 95(4): 1539-1544. [9] Nelson KC, Zhao ML, Schroeder PR, et al. Role of different pathways of the complement cascade in experimental bullous pemphigoid. J Clin Invest, 2006, 116(11): 2892-2900. [10] Liu Z, Giudice GJ, Swartz SJ, et al. Role of FcRs in animal model of autoimmune bullous pemphigoid. J Immunol, 2006, 177(5): 3398-3405. |